BridgeBio have substantially advanced the course of a novel treatment for ATTR-CM, utilizing the investigational drug. Preliminary trial information reveals potential benefits for individuals diagnosed from the severe https://bridgebio036384.blogs-service.com/73278717/firm-advances-attr-cm-therapy-with-the-drug